請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/83031| 標題: | 乙醯半胱氨酸和滴舒適點眼液在大鼠乾眼症模型上對角膜上皮傷口癒合的影響 The effects of N-acetylcysteine and diquafosol on corneal epithelial wound healing in a dry eye rat model |
| 作者: | 吳羿穎 Yi-Ying Wu |
| 指導教授: | 林中天 Chung-Tien Lin |
| 共同指導教授: | 胡芳蓉;孫逸珍 Fung-Rong Hu;Yi-Chen Sun |
| 關鍵字: | 乾眼症; 角膜上皮傷口; 癒合速度; 滴舒適®點眼液; 乙醯半胱氨酸; 基 質金屬蛋白酵素 9 dry eye; corneal epithelial wound; wound healing; diquafosol; N-acetylcysteine; MMP-9 |
| 出版年 : | 2021 |
| 學位: | 碩士 |
| 摘要: | 背景:屈光不正是常見造成視力受損的原因之一,其中最常見的情況為近視。雷射屈光角膜切削術(Photorefractive keratectomy,縮寫PRK)為其中一種角膜屈光手術方式,此方法最大的不同點是手術過程中需要移除角膜上皮。同時,乾眼症也是常見的眼科疾病之一,已知配戴隱形眼鏡為患有乾眼症的風險因子之一,因此可以得知可能有部分的近視病患同時患有乾眼症。若是患有乾眼症的病患需要進行雷射屈光角膜切削術時,可能會承受比其他病患更多的副作用。若有點眼藥物能夠促進乾眼症病患的角膜上皮傷口癒合速度,也許能夠減輕這些病患的不適程度、達到更好的預後。近年來,一種黏蛋白促泌劑,滴舒適®點眼液(3% diquafosol sodium)逐漸被用來當作新興的乾眼症治療方法,而乙醯半胱氨酸(0.66%, 3%, 10% N-acetylcysteine)則是一種可以溶解黏液的藥物,臨床上曾用來治療乾眼症病患的黏液斑(mucous plaque)卻也有研究用其來誘導黏蛋白不足型的乾眼症模型。因此,為了瞭解這兩種藥物對於乾眼症病患的效果以及對於乾眼症病患的角膜傷口癒合的影響,本研究將這兩種藥物使用在同時具有乾眼症以及角膜上皮傷口的大鼠模型上進行分析。
目的:在乾眼症的大鼠模型上製造角膜上皮傷口,以模擬這些病患的狀況,接著觀察滴舒適®點眼液(3% diquafosol sodium)和三種不同濃度的乙醯半胱氨酸(0.66%, 3%, 10% N-acetylcysteine)在正常情況下以及乾眼症情況下,對角膜上皮傷口癒合和對角膜基質金屬蛋白酵素9(Matrix metalloproteinase-9,縮寫MMP-9)的影響。 方法:將18隻Sprague-Dawley大鼠隨機分成6組:控制組、DQS組、0.66% NAC組、3% NAC組、10% NAC組和乾眼症控制(沒有誘導角膜傷口且沒有給予任何眼藥水治療)組,而每隻大鼠的右眼為治療眼、左眼則為控制眼。第0天時,所有大鼠右眼的眶外淚腺(extraorbital lacrimal gland)和眼後淚腺(infraorbital lacrimal gland)皆會手術切除。第2天時,五個治療組的大鼠雙眼皆會進行角膜上皮傷口誘導手術,並在術後開始給予一天四次的眼藥水,包含了預防性的抗生素眼藥水以及各組指定的眼藥水。乾眼症控制組的大鼠不會接受此手術以及任何眼藥水。角膜上皮傷口製造後的第0, 8, 24, 32, 48, 72小時,會進行傷口大小的評估及拍照紀錄。第72小時後,所有大鼠皆會進行犧牲,並將角膜完整取下進行即時聚合酶連鎖反應(Real-time polymerase chain reaction)分析其基質金屬蛋白酵素9的表現量。大鼠的淚水量、傷口癒合速度及角膜基質金屬蛋白酵素9的表現量等皆會進行統計分析。 結果:切除淚腺後的右眼其淚水量在術後一天淚水量顯著下降直到實驗結束,左眼的淚水量皆維持與第0天相似的值,其中左眼可看到淚水量在第3天時有上升的情形,可能與角膜傷口造成的疼痛刺激有關。在每一組別中的大鼠,切除淚腺後的右眼其角膜螢光染色的評分在進行角膜上皮傷口誘導前,皆顯示顯著上升,代表所有大鼠的右眼角膜表面皆出現了顯著的乾眼症變化。在五組治療組中,每一組角膜上皮傷口癒合的速度右眼皆顯著較左眼慢。而在各組的右眼傷口,術後48小時為止各組間傷口的傷口大小皆無顯著差異,而在術後72小時,0.66% NAC和10% NAC兩組的角膜傷口皆顯著較控制組大。而各組的左眼傷口,在術後第24小時,0.66% NAC和10% NAC兩組的傷口面積皆顯著較DQS和控制組大,而術後第32小時,0.66% NAC、3% NAC和10% NAC三組的傷口面積皆顯著較控制組大。而各組角膜的基質金屬蛋白酵素9表現量,右眼皆顯著比左眼高。各組的左眼之間沒有顯著的差異; 各組的右眼間控制組顯著較其他四組治療組高,其中DQS和3% NAC兩組的表現量也顯著較10% NAC組高。控制組和乾眼症控制組相比,控制組右眼的基質金屬蛋白酵素9表現量也顯著較乾眼症組的右眼高。 結論:滴舒適®點眼液和三種不同濃度的乙醯半胱氨酸在正常眼和患有乾眼症的眼睛上,都無法顯著促進角膜上皮傷口的癒合,其中0.66% NAC和10% NAC可能會延緩傷口的癒合。在乾眼症病患的治療上,滴舒適®點眼液和乙醯半胱氨酸皆是可能會使用的藥物,但這些藥物在病患有角膜上皮傷口時使用,可能會延緩角膜上皮傷口的癒合速度。在乾眼症病患上,抑制角膜基質金屬蛋白酵素9的表現量並不是能夠促進角膜上皮傷口癒合的治療方向。 Background: Refractive error is one of the most common causes of reversible visual impairment. Among these refractive error conditions, myopia is the most common problem. Photorefractive keratectomy (PRK) is one of the corrective refractive surgeries. The most specific procedure of PRK is the removal of corneal epithelium. Besides, dry eye disease is also one of the general ocular diseases. And, contact lens use is one of the risk factors of dry eye disease. It means that there are part of myopia patients may also suffer from dry eye disease. However, the patient who would like to receive PRK surgery with pre-existing dry eye disease may suffer more pain than others. Drugs that can improve corneal epithelial wound healing in dry eye patient may substantially diminish the side effects. Recently, the mucin secretagogues, diquafosol eye drops, is used as a novel therapeutic option of dry eye disease. On the contrary, N-acetylcysteine is a mucolytic agent. In prior literatures, the drugs had been used to treat mucous plaques in dry eye patients. However, it also been used to induce mucin-deficiency dry eye animal model. In order to investigate the effect of these two drugs on dry eye patient and on wound healing, we applied these two drugs to animal models which suffered both dry eye disease and corneal epithelial wound. Purposes: We tried to build up a dry eye rat model and mimicked the PRK surgery to induce the corneal epithelial wound. Then, the effect of diquafosol and three different concentrations of N-acetylcysteine on corneal epithelial wound healing and MMP-9 expression level were evaluated. Methods: Eighteen Sprague-Dawley were randomly divided into six groups, such as control group, DQS group, 0.66% NAC group, 3% NAC group, 10% NAC group and dry eye control group. On Day 0, all rats underwent extraorbital and infraorbital lacrimal gland excision surgery on their right eye. Then, on Day 2, all rats underwent corneal epithelial wound induction surgery on both eyes except dry eye control group. The rats in dry eye control group did not induce corneal epithelial wound nor received any eye drops. After corneal wound surgery, topical antibiotics eye drops and designated drugs were administrated four times daily. And, corneal wound evaluation was performed at post-surgery 0, 8, 24, 32, 48 and 72 h. All rats were sacrificed at 72 h post-surgery. The corneal tissue was completely removed and analyzed for the MMP-9 expression level by real-time PCR. Statistical analysis of tear secretion, corneal wound healing rate and corneal MMP-9 expression level was performed. Results: Tear secretion of right eye significantly decreased from one day post-excision of lacrimal gland till the end of the study. And, the corneal fluorescein stain score of right eyes also significantly increased on day 2 in all rats, which meant that dry eye symptoms were shown in all right eyes before corneal epithelial wound induction surgery. The corneal epithelial wound healing rate was significantly slower in right eye compared to left eye in every groups. And, there was no obvious difference in corneal wound size before 48 h post-surgery in right eye of each group. At 72 h, the area of corneal wound of right eye was significantly larger in 0.66% NAC and 10% NAC group than in control group. On the other hand, the area of corneal wound of left eye was significantly larger in 0.66% NAC and 10% NAC than in control and DQS group at 24 h. At 32 h, the corneal wound size of left eye was significantly bigger in 0.66% NAC, 3% NAC and 10% NAC than in control group. Lastly, the corneal MMP-9 expression level was significantly higher in right eye than in left eye in all six groups. Moreover, the MMP-9 expression level of right eye was significantly lower in DQS group, 0.66% NAC, 3% NAC and 10% NAC group than in control group. Among these, MMP-9 expression level in 10% NAC was the lowest. Compared the right eye of control group with dry eye control group, the MMP-9 expression level was significantly higher in the control group. Conclusions: Diquafosol and three different concentrations of N-acetylcysteine could not improve corneal epithelial wound healing in both normal condition and dry eye condition. Diquafosol as well as N-acetylcysteine were therapeutic options of dry eye disease. However, it should take into account that these two drugs may retard corneal epithelial wound healing in dry eye patients. Lastly, suppression of corneal MMP-9 expression was not the right approach to improve corneal epithelial wound healing in dry eye patient. |
| URI: | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/83031 |
| DOI: | 10.6342/NTU202104250 |
| 全文授權: | 未授權 |
| 電子全文公開日期: | 2026-10-01 |
| 顯示於系所單位: | 臨床動物醫學研究所 |
文件中的檔案:
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-109-2.pdf 未授權公開取用 | 36.5 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。
